Description
The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada | Open resource | ||
| Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada | Open resource | ||
| Infographic: Summary of RSV vaccine products in late-stage development | Open resource | ||
| Infographic: Summary of RSV vaccine products in late-stage development | Open resource | ||
| Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat | Open resource | ||
| Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat | Open resource | ||
| Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 | Open resource | ||
| Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 | Open resource | ||
| Measles surveillance in Canada: 2018 | Open resource | ||
| Measles surveillance in Canada: 2018 | Open resource | ||
| Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 | Open resource | ||
| Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 | Open resource | ||
| Motivational interviewing: A powerful tool to address vaccine hesitancy | Open resource | ||
| Motivational interviewing: A powerful tool to address vaccine hesitancy | Open resource | ||
| Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) | Open resource | ||
| Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) | Open resource | ||
| CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) | Open resource | ||
| CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) | Open resource | ||
| Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada | HTML | Open resource | |
| Infographic: Summary of RSV vaccine products in late-stage development | HTML | Open resource | |
| Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat | HTML | Open resource | |
| Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 | HTML | Open resource | |
| Measles surveillance in Canada: 2018 | HTML | Open resource | |
| Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 | HTML | Open resource | |
| Motivational interviewing: A powerful tool to address vaccine hesitancy | HTML | Open resource | |
| Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) | HTML | Open resource | |
| CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) | HTML | Open resource | |
| Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada | HTML | Open resource | |
| Infographic: Summary of RSV vaccine products in late-stage development | HTML | Open resource | |
| Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat | HTML | Open resource | |
| Large community mumps outbreak in Manitoba, Canada, September 2016–December 2018 | HTML | Open resource | |
| Measles surveillance in Canada: 2018 | HTML | Open resource | |
| Risk factors for drug-resistant tuberculosis at a referral centre in Toronto, Ontario, Canada: 2010–2016 | HTML | Open resource | |
| Motivational interviewing: A powerful tool to address vaccine hesitancy | HTML | Open resource | |
| Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists; Coronavirus disease (COVID-19) | HTML | Open resource | |
| CCDR: Volume 46-04 -April 2020: Respiratory syncytial virus (RSV) | HTML | Open resource |